Hemogenyx Pharmaceuticals PLC
F:5HU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hemogenyx Pharmaceuticals PLC
F:5HU
|
UK |
|
Gusbourne PLC
F:S8E
|
UK |
|
DCD Media PLC
LSE:DCD
|
UK |
|
S
|
Sandoll Inc
KOSDAQ:419120
|
KR |
|
P
|
Pegasus Resources Inc
OTC:SLTFF
|
CA |
|
Mayfair Gold Corp
F:9M50
|
CA |
|
B
|
Bayview Acquisition Corp
NASDAQ:BAYA
|
US |
|
Yaskawa Electric Corp
OTC:YASKF
|
JP |
|
P
|
Plymouth Rock Technologies Inc
CNSX:PRT
|
CA |
|
Real Luck Group Ltd
OTC:LUKEF
|
CA |
|
I
|
Inswave Systems Co Ltd
KOSDAQ:450520
|
KR |
|
K
|
KX HiTech Co Ltd
KOSDAQ:052900
|
KR |
|
Assured Guaranty Ltd
NYSE:AGO
|
BM |
|
A
|
Atlantica Inc
OTC:ALDA
|
US |
|
D
|
Digital Space SA
WSE:NFP
|
PL |
|
Waratah Minerals Ltd
ASX:WTM
|
AU |
|
A
|
Aeffe SpA
SWB:3A1
|
IT |
|
Triangle Energy (Global) Ltd
ASX:TEG
|
AU |
|
Kedawung Setia Industrial Tbk PT
IDX:KDSI
|
ID |
|
S
|
Simpson Manufacturing Co Inc
XMUN:TWL
|
US |
|
Nickel Asia Corp
OTC:NCKAF
|
PH |
Bankruptcy Probability
Hemogenyx Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hemogenyx Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
40m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hemogenyx Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hemogenyx Pharmaceuticals PLC has total debt of 1.8m GBP. This includes both short-term (0 GBP) and long-term (1.8m GBP) debt.
You can find a full breakdown on its Balance Sheet.
